Form 8-K Citius Pharmaceuticals, For: Mar 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Citius Pharmaceuticals (CTXR) Granted Nasdaq Hearing
March 13, 2024 4:34 PM EDTOn March 12, 2024, Citius Pharmaceuticals (NASDAQ: CTXR) received formal notice that the Nasdaq Stock Market LLC (Nasdaq) granted our request for an extension through September 9, 2024 (the Extension Notice) to evidence compliance with the $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Bid... More
